Multiple_Myeloma_Research_Review_Issue_43Download
Research
Multiple Myeloma Research Review
Multiple_Myeloma_Research_Review_Issue_42Download
FRAIL-M TRIALS FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE I/II)
Frail-M test
Covid-19: ‘Not fair’ unvaccinated will force mum with blood cancer to stay ‘locked’ in home for remaining years
Nichola Oakenfull is partially vaccinated against Covid-19, but she’s still scared. The Wellington woman was diagnosed...
Paediatric oncology parents are pleased with quality of care despite pandemic
This article originally published on The Limbic Most parents of children undergoing active cancer treatment at the RCH Children’s Cancer Centre,...
PVd triplet therapy now on PBS for MM patients after first relapse
Pomalidomide (Pomalyst) in combination with bortezomib and dexamethasone (PVd) will be reimbursed on the PBS from 1 October for patients with...
ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax
People with blood cancers who are immunocompromised are now advised to have a third primary dose of COVID-19 vaccine with an mRNA vaccine. On 8...
‘I am screwed if it comes back’: Experts concerned by Covid’s hidden impact on blood cancer treatments
This article was originally posted on Stuff Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to recognise, and experts...
Distress doubles for blood cancer patients during pandemic
This article was originally published on The Limbic Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher...
Isatuximab another string in the bow for management of RRMM
This article was originally posted on The Limbic Addition of isatuximab to carfilzomib–dexamethasone has been hailed “a new standard of care” for...
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recently, MM was redefined to include biomarkers...
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
This Policy Review presents the International Myeloma Working Group’s clinical practice recommendations for the treatment...